Atika Capital Management »

Rapt Therapeutics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 94k 33.87

More positions owned by Atika Capital Management

Robinhood Mkts Com Cl A Put Option (HOOD)
Spdr Series Trust State Street Spd Put Option (XBI)
Vertiv Holdings Com Cl A (VRT)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Shopify Cl A Sub Vtg Shs (SHOP)
Madrigal Pharmaceuticals (MDGL)
Bwx Technologies (BWXT)
Amazon (AMZN)
Cogent Biosciences (COGT)
Netflix (NFLX)
Talen Energy Corp (TLN)
Seagate Technology Hldngs Ord Shs (STX)

View all positions for Atika Capital Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics